Vyvanse and Teriflunomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Teriflunomide (teriflunomide). Common drug interactions include multiple sclerosis relapse among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Teriflunomide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.

What is Teriflunomide?

Teriflunomide has active ingredients of teriflunomide. eHealthMe is studying from 5,067 Teriflunomide users. Check the latest studies of Teriflunomide.

On Aug, 09, 2026

13 people who take Vyvanse and Teriflunomide together, and have interactions are studied.

Vyvanse and Teriflunomide drug interactions.

What are the common drug interactions of Vyvanse and Teriflunomide, by gender? *:

female:

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Alopecia (absence of hair from areas of the body)
Dysphagia (a condition in which swallowing is difficult or painful)
Hypoaesthesia (reduced sense of touch or sensation)
Pruritus (severe itching of the skin)
Visual impairment
Gait disturbance
Abdominal pain upper
Eye pruritus (eye itching)
Furuncle (infection of the hair follicle)

male:

Anxiety
Abdominal pain upper
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Decreased appetite
Energy increased
Pain in extremity
Pericardial effusion (fluid around the heart)
Weight decreased
Anger
Dizziness

What are the common drug interactions of Vyvanse and Teriflunomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

40-49:

Alopecia (absence of hair from areas of the body)
Dysphagia (a condition in which swallowing is difficult or painful)
Hypoaesthesia (reduced sense of touch or sensation)
Pruritus (severe itching of the skin)
Visual impairment
Hypertension (high blood pressure)
Abdominal pain upper
Eye pruritus (eye itching)
Furuncle (infection of the hair follicle)
Hot flush (sudden feelings of heat)

50-59:

Drug ineffective

60+:

Asthenia (weakness)
Feeding disorder (when children refuse to eat certain food groups)
Energy increased
Pain in extremity
Pericardial effusion (fluid around the heart)
Weight decreased
Gait disturbance
Gallbladder disorder
Memory impairment
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 76.92%
Depression: 3 people, 23.08%
Stress And Anxiety: 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Fatigue (feeling of tiredness): 2 people, 15.38%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 7.69%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.69%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.69%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and Teriflunomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously